HCAT Stock Analysis: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$2.09
0.01 (0.48%)
▲
5d:
+0.48%
30d:
+0.97%
90d:
+67.2%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HCAT shows positive signals but monitor for confirmation. Market pricing in 28.1% growth. Moderate conviction.
💡 BUY OPPORTUNITY: HCAT shows positive signals but monitor for confirmation. Market pricing in 28.1% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $2.09, which is considered fair relative to its 30-day fair value range of $1.96 to $2.27. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.6) compared to its historical average (10.8). At these levels, the market is pricing in 28.1% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a strong uptrend. Immediate support is located at $2.01, while resistance sits at $2.25.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HCAT is in a strong uptrend. Immediate support is located at $2.01, while resistance sits at $2.25.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.96 -
$2.27
Company Quality Score
48/100
(HOLD)
Options IV Signal
1th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 1th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($2.25)
- BEARISH: Market expects 28.1% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$1.96 -
$2.27
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.34
(16.4%)
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.25
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.64
Wall Street Target
$2.25
(+7.7%)
Revenue Growth (YoY)
-10.9%
Profit Margin
-87.7%
Valuation Premium vs History
+28.1% premium
PE vs Historical
22.6 vs 10.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+28.1%
(market-implied from PE analysis)
1-Year Target
$2.68
(+28%)
2-Year Target
$3.43
(+64%)
3-Year Target
$4.39
(+110%)
3-Yr Target (if PE normalizes)
(PE: 23→11)
PE COMPRESSION
$2.10
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: 119.8%)
$7.05
(+238%)
Base:
(SPY PE: 20.7, Growth: 119.8%)
$6.46
(+209%)
Bear:
(PE: 10.8, Growth: 119.8%)
$3.36
(+61%)
Share & Embed Analysis
Last updated: August 02, 2026 5:06 AM ET
Data refreshes hourly during market hours. Next update: 6:06 AM
Data refreshes hourly during market hours. Next update: 6:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$118 | 50 HOLD |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
